Kelly Lawrence W & Associates Inc Abb Vie Inc. Transaction History

Kelly Lawrence W & Associates Inc

$429 Million
Q1 2024

A detailed history of Kelly Lawrence W & Associates Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Kelly Lawrence W & Associates Inc holds 10,836 shares of ABBV stock, worth $1.86 Million. This represents 0.46% of its overall portfolio holdings.

Number of Shares

10,836

Previous 10,951 1.05%

Holding current value

$1.86 Million

Previous $1.7 Million 16.26%

% of portfolio

0.46%

Previous 0.41%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$159.82 - $182.1 $18,379 - $20,941	-115 Reduced 1.05%	10,836 $1.97 Million
Q3 2023 Nov 14, 2023	SELL	$133.59 - $154.65 $13,359 - $15,465	-100 Reduced 0.9%	10,951 $1.63 Million
Q2 2023 Aug 14, 2023	SELL	$132.51 - $164.9 $287,149 - $357,338	-2,167 Reduced 16.39%	11,051 $1.49 Million
Q3 2022 Nov 15, 2022	SELL	$134.21 - $153.93 $33,552 - $38,482	-250 Reduced 1.86%	13,218 $1.77 Million
Q1 2022 May 16, 2022	SELL	$131.98 - $163.75 $44,213 - $54,856	-335 Reduced 2.43%	13,468 $2.18 Million

Q4 2021 Feb 11, 2022	SELL	$107.43 - $135.93 $79,713 - $100,860	-742 Reduced 5.1%	13,803 $1.87 Million
Q2 2021 Aug 16, 2021	BUY	$105.21 - $117.21 $21,042 - $23,442	200 Added 1.39%	14,545 $1.64 Million
Q1 2021 May 17, 2021	BUY	$102.3 - $112.62 $1.01 Million - $1.11 Million	9,860 Added 219.84%	14,345 $1.55 Million
Q4 2020 Feb 12, 2021	SELL	$80.49 - $108.67 $938,513 - $1.27 Million	-11,660 Reduced 72.22%	4,485 $481,000
Q4 2018 Feb 14, 2019	SELL	$77.85 - $96.01 $692,865 - $854,489	-8,900 Reduced 35.54%	16,145 $1.49 Million
Q2 2018 Aug 14, 2018	SELL	$89.78 - $106.23 $8,978 - $10,623	-100 Reduced 0.4%	25,045 $2.32 Million
Q1 2018 May 15, 2018	SELL	$92.01 - $123.21 $110,412 - $147,852	-1,200 Reduced 4.55%	25,145 $2.38 Million
Q4 2017 Feb 14, 2018	SELL	$89.56 - $98.21 $22,390 - $24,552	-250 Reduced 0.94%	26,345 $2.55 Million
Q3 2017 Nov 15, 2017	BUY	$69.85 - $89.22 $1.86 Million - $2.37 Million	26,595	26,595 $2.36 Million

Others Institutions Holding ABBV

# of Institutions

3,651

Shares Held

1.24B

Call Options Held

15.5M

Put Options Held

11.6M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $303B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kelly Lawrence W & Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Kelly Lawrence W & Associates Inc with notifications on news.

Account

Kelly Lawrence W & Associates Inc Abb Vie Inc. Transaction History